http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101416954-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2303 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-998 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-48 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0641 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0642 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02 |
| filingDate | 2012-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101416954-B1 |
| titleOfInvention | Method for inducing the differentiation of the hematopoietic cell |
| abstract | The present invention relates to the production of in vitro erythrocyte / granulocyte and the treatment of myelodysplastic syndrome using the hematopoietic cell differentiation inducing method. The present invention relates to a method for inducing differentiation from hematopoietic progenitor cells containing erythrocyte / granulocyte as an active ingredient A pharmaceutical composition for the treatment of myelodysplastic syndrome comprising a culture medium composition and gelsolin as an active ingredient. The composition of the present invention has an effect of improving the differentiation efficiency of hematopoietic progenitor cells into erythrocyte / granulocyte, lowering the incidence of cell dysplasia, enhancing the enucleation rate and cell survival rate, and is useful for the treatment of in vitro erythrocyte / granulocyte production and myelodysplastic syndrome Lt; / RTI > |
| priorityDate | 2012-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 143.